Short-term anti-remodeling effects of gliflozins in diabetic patients with heart failure and reduced ejection fraction: an explainable artificial intelligence approach

Introduction: Sodium-glucose cotransporter type 2 inhibitors (SGLT2i), gliflozins, play an emerging role for the treatment of heart failure with reduced left ventricular ejection fraction (HFrEF). Nevertheless, the effects of SGLT2i on ventricular remodeling and function have not been completely und...

Descripción completa

Detalles Bibliográficos
Autores principales: Mele, Marco, Imbrici, Paola, Mele, Antonietta, Togo, Maria Vittoria, Dinoi, Giorgia, Correale, Michele, Brunetti, Natale Daniele, Nicolotti, Orazio, De Luca, Annamaria, Altomare, Cosimo Damiano, Liantonio, Antonella, Amoroso, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289166/
https://www.ncbi.nlm.nih.gov/pubmed/37361206
http://dx.doi.org/10.3389/fphar.2023.1175606

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289166/
https://www.ncbi.nlm.nih.gov/pubmed/37361206
http://dx.doi.org/10.3389/fphar.2023.1175606

Ejemplares similares